Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mehrdad Abedi

Showing results (11-20 of 67) with videos related to

Pageof 7
Sort By:
Bone Marrow Transplantation|September 2, 2021
Safety and tolerability of lenalidomide maintenance in post-transplant acute myeloid leukemia and high-risk myelodysplastic syndromeBrian Pham, Rasmus Hoeg, Rajeev Krishnan, et al.
Cancers|December 24, 2015
Acute Myeloid Leukemia with Isolated Trisomy 19 Associated with Diffuse Myelofibrosis and OsteosclerosisAdam Stelling, Brian A Jonas, Hooman H Rashidi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 6, 2016
Therapeutic Effects of a NEDD8-Activating Enzyme Inhibitor, Pevonedistat, on Sclerodermatous Graft-versus-Host Disease in MiceChien-Chun Steven Pai, Lam T Khuat, Mingyi Chen, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 16, 2020
A Phase I Study of Everolimus and Bendamustine in Patients With Relapsed/Refractory Lymphoid Hematologic MalignanciesRasmus T Hoeg, Julian Davis, Brian A Jonas, et al.
Transplantation and Cellular Therapy|June 25, 2026
A Retrospective Study Evaluating the Efficacy of Fludarabine, Cytarabine, and Granulocyte Colony Stimulating Factor with/without Idarubicin Followed by Second Allogenic Stem Cell Transplant in the Treatment of Relapsed/Refractory AML/MDS Following First Allogenic Stem Cell TransplantJacqueline Hsieh-Wong, Brian Pham, Joseph Tuscano, et al.
Blood Cells, Molecules & Diseases|February 6, 2004
Targeting of Lin-Sca+ hematopoietic stem cells with bispecific antibodies to injured myocardiumLawrence G Lum, Hubert Fok, Richard Sievers, et al.
In Vitro Cellular & Developmental Biology. Animal|January 7, 2003
Rhythmicity of engraftment and altered cell cycle kinetics of cytokine-cultured murine marrow in simulated microgravity compared with static culturesGerald A Colvin, Jean-François Lambert, Jane E Carlson, et al.
Ophthalmology Science|September 27, 2024
Phase I Study of Intravitreal Injection of Autologous CD34+ Stem Cells from Bone Marrow in Eyes with Vision Loss from Retinitis PigmentosaSusanna S Park, Gerhard Bauer, Brian Fury, et al.
American Journal of Hematology|January 21, 2021
Phase I study of escalating doses of carfilzomib with HyperCVAD in patients with newly diagnosed acute lymphoblastic leukemiaBrian A Jonas, Samantha C Fisch, Aaron S Rosenberg, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 29, 2010
Biglycan recruits utrophin to the sarcolemma and counters dystrophic pathology in mdx miceAlison R Amenta, Atilgan Yilmaz, Sasha Bogdanovich, et al.
Pageof 7

Showing results (11-20 of 67) with videos related to

Sort By:
Pageof 7
Bone Marrow Transplantation|September 2, 2021
Safety and tolerability of lenalidomide maintenance in post-transplant acute myeloid leukemia and high-risk myelodysplastic syndromeBrian Pham, Rasmus Hoeg, Rajeev Krishnan, et al.
Cancers|December 24, 2015
Acute Myeloid Leukemia with Isolated Trisomy 19 Associated with Diffuse Myelofibrosis and OsteosclerosisAdam Stelling, Brian A Jonas, Hooman H Rashidi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 6, 2016
Therapeutic Effects of a NEDD8-Activating Enzyme Inhibitor, Pevonedistat, on Sclerodermatous Graft-versus-Host Disease in MiceChien-Chun Steven Pai, Lam T Khuat, Mingyi Chen, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 16, 2020
A Phase I Study of Everolimus and Bendamustine in Patients With Relapsed/Refractory Lymphoid Hematologic MalignanciesRasmus T Hoeg, Julian Davis, Brian A Jonas, et al.
Transplantation and Cellular Therapy|June 25, 2026
A Retrospective Study Evaluating the Efficacy of Fludarabine, Cytarabine, and Granulocyte Colony Stimulating Factor with/without Idarubicin Followed by Second Allogenic Stem Cell Transplant in the Treatment of Relapsed/Refractory AML/MDS Following First Allogenic Stem Cell TransplantJacqueline Hsieh-Wong, Brian Pham, Joseph Tuscano, et al.
Blood Cells, Molecules & Diseases|February 6, 2004
Targeting of Lin-Sca+ hematopoietic stem cells with bispecific antibodies to injured myocardiumLawrence G Lum, Hubert Fok, Richard Sievers, et al.
In Vitro Cellular & Developmental Biology. Animal|January 7, 2003
Rhythmicity of engraftment and altered cell cycle kinetics of cytokine-cultured murine marrow in simulated microgravity compared with static culturesGerald A Colvin, Jean-François Lambert, Jane E Carlson, et al.
Ophthalmology Science|September 27, 2024
Phase I Study of Intravitreal Injection of Autologous CD34+ Stem Cells from Bone Marrow in Eyes with Vision Loss from Retinitis PigmentosaSusanna S Park, Gerhard Bauer, Brian Fury, et al.
American Journal of Hematology|January 21, 2021
Phase I study of escalating doses of carfilzomib with HyperCVAD in patients with newly diagnosed acute lymphoblastic leukemiaBrian A Jonas, Samantha C Fisch, Aaron S Rosenberg, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 29, 2010
Biglycan recruits utrophin to the sarcolemma and counters dystrophic pathology in mdx miceAlison R Amenta, Atilgan Yilmaz, Sasha Bogdanovich, et al.
Pageof 7